 Creatinine
"Creatinine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
No definition found.
| Descriptor ID |
D003404
|
| MeSH Number(s) |
D03.383.129.308.207
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Creatinine".
Below are MeSH descriptors whose meaning is more specific than "Creatinine".
This graph shows the total number of publications written about "Creatinine" by people in this website by year, and whether "Creatinine" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 | | 1997 | 0 | 1 | 1 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 3 | 3 | | 2000 | 0 | 6 | 6 | | 2001 | 1 | 2 | 3 | | 2002 | 2 | 5 | 7 | | 2003 | 1 | 7 | 8 | | 2004 | 0 | 9 | 9 | | 2005 | 0 | 10 | 10 | | 2006 | 2 | 6 | 8 | | 2007 | 0 | 14 | 14 | | 2008 | 3 | 20 | 23 | | 2009 | 0 | 11 | 11 | | 2010 | 3 | 13 | 16 | | 2011 | 0 | 10 | 10 | | 2012 | 4 | 11 | 15 | | 2013 | 4 | 9 | 13 | | 2014 | 2 | 14 | 16 | | 2015 | 4 | 13 | 17 | | 2016 | 2 | 11 | 13 | | 2017 | 1 | 10 | 11 | | 2018 | 4 | 10 | 14 | | 2019 | 3 | 10 | 13 | | 2020 | 2 | 15 | 17 | | 2021 | 0 | 12 | 12 | | 2022 | 0 | 16 | 16 | | 2023 | 0 | 13 | 13 | | 2024 | 1 | 4 | 5 | | 2025 | 1 | 9 | 10 | | 2026 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Creatinine" by people in Profiles.
-
Moedt E, Ju W, Nair V, Bjornstad P, Kretzler M, Heerspink HJL. Novel protein biomarkers for risk stratification and personalized medicine. Nephrol Dial Transplant. 2026 Aug 25; 41(Supplement_2):ii50-ii58.
-
Edwards MH, Nicklawksy A, Iguchi N, Beltran G, Milgrom S, Cost NG. Urinary Biomarkers in Childhood Cancer Survivors With Lower Urinary Tract Dysfunction. Urology. 2026 Sep; 215:126-130.
-
Vivarelli M, Ariceta G, Borovitz Y, Dixon BP, Greenbaum LA, Licht C, Mastrangelo A, Melhem N, Fujita N, van de Kar NCAJ, Wallace D, Khankin E, Wang Z, López-Lázaro L, Szamosi J, Nester CM. Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis. Clin J Am Soc Nephrol. 2026 Aug 01; 21(8):1404-1413.
-
Balamuth F, Weiss SL, Long E, Thompson GC, Artis AS, Campos AB, Borland ML, Dalziel SR, Yock-Corrales A, Singh R, Williams A, Mickiewicz B, Hickey CP, Fitzgerald JC, Laskin BL, Hickey RW, Eckerle M, Alqurashi W, Alpern E, Ambroggio L, Badawy M, Baumer-Mouradian S, Berthelot S, Clukies LD, Craig S, Curtis SJ, Davis AL, Duffy S, Eisenberg MA, Emsley JG, Festekjian A, George S, Green R, Gripp KE, Jain PG, Jani S, Joubert GI, Judge P, Kam A, Kochar A, Koutroulis I, Kwok MY, Lane RD, Lithgow A, Lloyd J, Mansour K, McManemy JK, Morris C, Phillips N, Rao A, Rogers A, Sehgal A, Shayan Y, Silverman J, Tan E, Uspal NG, Vance C, Whyte E, Huang J, Freedman SB, Babl FE, Kuppermann N. Balanced Fluid or 0.9% Saline in Children Treated for Septic Shock. N Engl J Med. 2026 Sep 03; 395(9):870-881.
-
Moedt E, Koshino A, Jongs N, Ju W, Nair V, Kretzler M, Hansen MK, Arnott CG, Wheeler DC, Rossing P, Coca SG, Hammarstedt A, Greasley PJ, Bjornstad P, Bakker SJL, Heerspink HJL. Association of Urinary EGF with Kidney Outcomes and Effects of Sodium-Glucose Cotransporter 2 Inhibition. J Am Soc Nephrol. 2026 Oct 01; 37(10):2210-2220.
-
Kwok R, Kishore K, Zafari T, Koye DN, Hachem M, de Boer IH, Jeong TD, Min WK, Porrini E, Bjornstad P, Tham YC, MacIsaac RJ, Churilov L, Ekinci EI. RenoTrue: A diabetes-specific machine learning model to estimate glomerular filtration rate for people with diabetes. Diabetes Res Clin Pract. 2026 Mar; 233:113137.
-
Butler-Dawson J, Jaramillo D, Krisher L, Hernandez KV, Calvimontes L, Erlandson G, Seidel J, Castro C, Brindley S, Li Y, Dally M, James KA, Johnson RJ, Pilloni D, Cruz A, Smith N, Johnson E, Schaeffer JW, Adgate JL, Newman LS. Evaluating the effects of heat strain and air pollution on kidney health. Environ Int. 2026 Jan; 207:110042.
-
Dobson A, MacLaren R, Pons S, Krey M. Estimating GFR Using Creatinine, Cystatin C, or Both and the Impact on Predicted Vancomycin Half-Life. Ann Pharmacother. 2026 Sep; 60(9):866-871.
-
Fakhouri F, Bomback AS, Ariceta G, Delmas Y, Dixon BP, Gale DP, Greenbaum LA, Han SH, Isbel N, Le Quintrec M, Licht C, Mastrangelo A, Mizuno M, Neves de Holanda MI, Pickering MC, Remuzzi G, Van De Kar N, Vivarelli M, Walker PD, Wallace D, Zecher D, Francois C, Deschatelets P, Li L, Wang Z, Abad-Franch L, Kinnman N, López-Lázaro L, Szamosi J, Nester CM. Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN. N Engl J Med. 2025 Dec 04; 393(22):2210-2220.
-
Steinke JM, Gist KM, Askenazi D, Ogden RK, Shin S, Sutherland S, Yonekawa K, Mahon AR, Fadrowski J, Misurac J, Semanik M, Goldstein SL. A multi-center collaborative highlights the differences in nephrotoxic medication exposure and associated AKI in pediatric bone marrow transplant, oncology, and pulmonary service lines. Pediatr Nephrol. 2026 Mar; 41(3):865-872.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|